Barriers to access to medicines for noncommunicable diseases for patients using the Brazilian Unified Health System (SUS)

Authors

  • Samara Ramalho Matta Federal Institute of Education, Science and Technology of Rio de Janeiro, Rio de Janeiro, Brazil; Oswaldo Cruz Foundation, National School of Public Health Sergio Arouca, Rio de Janeiro, Brasil https://orcid.org/0000-0002-3305-0157
  • Andréa Dâmaso Bertoldi Federal University of Pelotas, Epidemiology Graduation Program, Rio Grande do Sul, Brazil
  • Isabel Cristina Martins Emmerick Oswaldo Cruz Foundation, National School of Public Health Sergio Arouca, Rio de Janeiro, Brasil; UMass Memorial Healthcare - University of Massachusetts Medical School– Department of Surgery - Division of Thoracic Surgery Massachusetts, USA
  • Vera Lucia Luiza Oswaldo Cruz Foundation, National School of Public Health Sergio Arouca, Rio de Janeiro, Brasil
  • PNAUM Group

DOI:

https://doi.org/10.1590/s2175-979020200001181016

Keywords:

Health Services. Accessibility. Noncommunicable Diseases. Primary Health Care.

Abstract

This paper investigates difficulties related to access to medicines in SUS and factors associated with the inability to obtain medicines in SUS by non-communicable chronic disease (NCCD) patients who used this source for health care. We analyzed data from the National Survey on Access, Use and Promotion of Rational Use of Medicines. First analysis included individuals aged 20 years and over, diagnosed with at least one NCCD, with indication of medicine treatment and follow up of this disease (s) with a physician from SUS, and who reported having obtained some of the medicines in use from the SUS. The difficulties of obtaining medicines from SUS were investigated based on dimensions of access to medicines. Among 5. 155 individuals investigated, 65. 4% were women, 40 years old or older and 54. 3% residents of the Southeast region of Brazil. Aspects related to availability and waiting time to obtain medicines were the most significant reported barriers to access to medicines. Regional differences were found in basically all dimensions of access and the low availability of medicines in SUS pharmacies was the main reason cited for their search in private pharmacies.

Downloads

Download data is not yet available.

References

Bousquat A, Giovanella L, Fausto M C R, Fusaro E R, Mendonça M H M, Gagno J, et al. Tipologia da estrutura das unidades básicas de saúde brasileiras: os 5 R. Cad Saúde Pública. 2017;33(8).

Gonçalves FC, Cunha Faria CC da. O acesso aos serviços de saúde - uma análise na perspectiva do gênero. Revista Perquirere. 2016;13(1):135-1477.

Leite S N, Bernardo N L M, Álvares J, Guerra Junior A A, Costa E A , Acurcio F de A, et al. Medicine dispensing service in primary health care of SUS. Rev Saúde Públ. 2017;51(supl.2):11s.

Luiza V L, Chaves L A, Campos M R, Bertoldi A D, Silva R M, Bigdeli M, et al. Applying a health system perspective to the evolving Farmácia Popular medicines access programme in Brazil. BMJ Global Health. 2018;2(supl.3).

Luiza V L, Tavares N U L, Oliveira M A, Arrais P S D, Ramos L R , Pizzol T da S D, et al. Catastrophic expenditure on medicines in Brazil. Rev. Saúde Públ. 2016;50(supl.2):15s.

Luiza VL, Bermudez JAZ. Acesso a medicamentos: conceitos e polêmicas. In: Acesso a medicamentos: Derecho fundamental, papel del Estado. Rio de Janeiro: Escola Nacional de Saúde Pública, 2004.

Malta D C, Bernal R T I, Lima M G, Araújo S S C de, Silva M M A, Freitas M I, et al. Noncommunicable diseases and the use of health services: analysis of the National Health Survey in Brazil. Rev Saúde Públ. 2017;51(supl.1):4s.

Mendes L V, Campos M R, Chaves G C, Silva R M da, Freitas P da S, Costa K S, et al. Disponibilidade de medicamentos nas unidades básicas de saúde e fatores relacionados: uma abordagem transversal. Saúde debate. 2014;38(n. special):109-123.

Mengue S S, Bertoldi A D, Boing A C, Tavares N U L, Pizzol T da S D, Oliveira M A, et al. National Survey on Access, Use and Promotion of Rational Use of Medicines (PNAUM): household survey component methods. Rev Saúde Públ. 2016;50(supl.2)4s.

Nascimento R C R M, Álvares J, Guerra A A, Gomes I C, Costa E A, Leite S N, et al. Disponibilidade de medicamentos essenciais na atenção primária do Sistema Único de Saúde. Rev Saúde Públ. 2017;51(supl.2):10s

Oliveira M A, Luiza V L, Tavares N U L, Mengue S S, Arrais P S D, Farias M R, et al. Access to medicines for chronic diseases in Brazil: a multidimensional approach. Rev Saúde Públ. 2016;50(supl.2):6s.

Rehem TCMSB, Egry EY. Internações por Condições Sensíveis à Atenção Primária no Estado de São Paulo. Ciênc Saúde Colet. 2011;16(12):4755-4766.

Schmidt M I, Duncan B B , Silva G A, Menezes A M, Monteiro C A, Barreto S M, et al. Chronic non-communicable diseases in Brazil: burden and current challenges. The Lancet. 2011;377(9781):1949-1961.

Silva RM da, Caetano R. Programa “Farmácia Popular do Brasil”: caracterização e evolução entre 2004-2012. Ciênc Saúde Colet. 2015;20(10):2943-2956.

Tavares N U L, Costa K S, Mengue S S, Vieira M L F P, Malta D C, Silva Júnior J B, et al. Uso de medicamentos para tratamento de doenças crônicas não transmissíveis no Brasil: resultados da Pesquisa Nacional de Saúde. Epidemiol. Serv Saúde. 2013; 24(2):315-323.

Vieira FS. Assistência farmacêutica no sistema público de saúde no Brasil. Rev. Panam. Salud Publ. 2010;27(2):149-156.

Vieira FS. Qualificação dos serviços farmacêuticos no Brasil: aspectos inconclusos da agenda do Sistema Único de Saúde. Rev Panam Salud Publ. 2008;24(2):91-100.

Yamauti SM, Barberato-Filho S, Lopes LC. Elenco de medicamentos do Programa Farmácia Popular do Brasil e a Política de Nacional Assistência Farmacêutica. Cad Saúde Pública. 2015;31(8):1648-1662.

Downloads

Published

2022-11-08

Issue

Section

Original Article

How to Cite

Barriers to access to medicines for noncommunicable diseases for patients using the Brazilian Unified Health System (SUS). (2022). Brazilian Journal of Pharmaceutical Sciences, 57. https://doi.org/10.1590/s2175-979020200001181016

Funding data